| 摘要 |
A method for treating anxiety in a patient by orally administering to said patient a daily dose of the active ingredient, 2-pyridinyl[7-(4-pyridinyl)pyrazolo[1,5-a]-pyrimidin-3-yl]-methanone or its pharmaceutically acceptable salts especially Ocinaplonin, in two separate divided administrations, with the first portion being administered in a slow release form and the remaining portion being administered in instant release form so as to maintain the blood levels of this active ingredient at therapeutically relevant levels to keep the anti anxiety effect in the patient during the periods between administrations of this active ingredient as well as pharmaceutical compositions containing this active ingredient for administration in connection with the above method. |
